Back to results
US 2019/0295683 A1Published application
Systems and methods for non-hormonal female contraceptive drug target identification and prioritization
AssigneeCelmatix, Inc.
InventorsPiraye Yurttas Beim, David Emlyn Parfitt, Mark Adams
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to systems and methods for identifying and prioritizing targets, specifically key genetic loci underlying one or more fertility disorders, for non-hormonal female contraceptive drug development.
Claims12
A method for screening for a non-hormonal female contraceptive therapeutic, the method comprising:
- identifying a gene or pathway known to function in female reproductive biology;
- exposing said gene or pathway to a candidate drug;
- and
- selecting, as a clinical candidate for a non-hormonal female contraceptive, a candidate non-hormonal female contraceptive drug that modulates said gene or pathway.
1 more element
Dependencies are inferred from the claim text.